07851nam 2200445 450 991046743780332120210831083713.01-4963-4895-8(CKB)4100000000880550(MiAaPQ)EBC5568212(Au-PeEL)EBL5568212(OCoLC)1061109804(EXLCZ)99410000000088055020181122d2017 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierNeurology evidence the practice-changing studies /Kate T. Brizzi [and three others]Philadelphia :Wolters Kluwer,[2017]©20171 online resource (337 pages)1-4963-4893-1 Intro -- Title Page -- Copyright -- DEDICATION -- CONTRIBUTORS -- FOREWORD -- PREFACE -- ACKNOWLEDGMENTS -- CONTENTS -- SECTION 1: ISCHEMIC STROKE -- 1. Intravenous tPA for Acute Ischemic Stroke -- 2. Aspirin for Secondary Stroke Prevention -- 3. Mechanical Thrombectomy for Large Vessel Occlusion -- 4. Harm from Stenting of Symptomatic Intracranial Arterial Stenoses -- 5. Warfarin for Atrial Fibrillation -- 6. Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation -- 7. Intense Low-Density Lipoprotein Cholesterol Reduction for Stroke Prevention -- 8. Marginal Benefit from Device Closure of Patent Foramen Ovale -- 9. Early Decompressive Surgery in Malignant Infarction of the Middle Cerebral Artery -- 10. Carotid Endarterectomy for Stroke Prevention in Internal Carotid Artery Stenosis -- 11. Carotid Artery Stenting vs. Carotid Endarterectomy For Symptomatic and Asymptomatic Carotid Artery Stenosis -- 12. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm -- 13. Short-Term Dual Antiplatelet Therapy for Stroke Prevention after TIA or Minor Stroke -- 14. Aspirin Over Warfarin for Symptomatic Intracranial Stenosis -- 15. Lack of Benefit from Long-Term Dual Antiplatelet Therapy for Secondary Stroke Prevention -- 16. Fluoxetine for Motor Recovery after Acute Ischemic Stroke -- 17. Carotid Endarterectomy for Asymptomatic Carotid Artery Stenosis -- 18. Extended Monitoring for Paroxysmal Atrial Fibrillation -- 19. The National Institutes of Health Stroke Scale -- SECTION 2: CEREBRAL HEMORRHAGE -- 20. Blood Pressure Regulation in Parenchymal Intracerebral Hemorrhage -- 21. Early Surgery for Spontaneous Intracerebral Hemorrhage and Hydrocephalus -- 22. Avoidance of Long-Term Anticoagulation for Atrial Fibrillation after Intracerebral Hemorrhage.23. Nimodipine for Prevention of Delayed Neurologic Injury after Subarachnoid Hemorrhage -- 24. Inferiority of Surgical Resection to Medical Management of Unruptured AVM -- 25. Prognostication for Intracerebral Hemorrhage -- 26. Acute Endovascular Treatment for Ruptured Subarachnoid Hemorrhage -- 27. Neurosurgical Clipping vs. Endovascular Coiling of Ruptured Intracranial Aneurysms -- 28. Withdrawal of Support in Intracerebral Hemorrhage because of Predicted Poor Prognosis May Lead to Self-Fulfilling Prophecy -- 29. rtPA for Intraventricular Hemorrhage -- 30. Grading of Ruptured Subarachnoid Hemorrhages -- SECTION 3: TRAUMATIC BRAIN INJURY -- 31. Glasgow Coma Scale -- 32. Albumin vs. Saline for Resuscitation after Traumatic Brain Injury -- 33. Decompressive Craniectomy in Traumatic Brain Injury -- 34. Antiepileptic Drugs after Traumatic Brain Injury -- 35. Intracranial Pressure Monitoring in Traumatic Brain Injury -- 36. Amantadine for Recovery of Consciousness after Traumatic Brain Injury -- 37. Functional Imaging in Vegetative States -- 38. Corticosteroids for Traumatic Brain Injury -- 39. Corticosteroids in Acute Spinal Cord Injury -- SECTION 4: NEUROLOGIC INTENSIVE CARE -- 40. Midline Shift and Level of Consciousness -- 41. Use of Hyperosmolar Therapy for Cerebral Edema -- 42. Hyperventilation for Acute Intracranial Pressure Elevation -- 43. Temperature Management for Cardiac Arrest in Adults -- 44. Early Mobilization in the Intensive Care Unit -- SECTION 5: NEUROINFECTIOUS DISEASES -- 45. Glucocorticoids for Bacterial Meningitis in Adults -- 46. Acyclovir for Herpes Simplex Encephalitis -- 47. Polymerase Chain Reaction Testing for Herpes Simplex Encephalitis -- 48. Antifungal Therapy for Cryptococcal Meningitis -- 49. Guidelines for Treatment of Lyme Disease in the Nervous System -- SECTION 6: NEURO-ONCOLOGY -- 50. Temozolomide for Glioblastoma.51. Surgery for Brain Metastases -- 52. Chemotherapy for Low-Grade Glioma -- 53. NovoTTF for Newly Diagnosed Glioblastoma -- 54. Bevacizumab for Recurrent Glioblastoma -- 55. Methotrexate for Primary CNS Lymphoma -- SECTION 7: NEUROMUSCULAR -- 56. Acute Treatment for Guillain-Barre Syndrome -- 57. Alternate Day Prednisone in Myasthenia Gravis -- 58. IVIg vs. Prednisone for Chronic Inflammatory Demyelinating Polyneuropathy -- 59. Glucocorticoid Steroids for Duchenne Muscular Dystrophy -- 60. Riluzole in Amyotrophic Lateral Sclerosis -- 61. Thymectomy in Myasthenia Gravis -- SECTION 8: MOVEMENT DISORDERS -- 62. L-Dopa for Parkinson's Disease -- 63. Deep Brain Stimulation for Parkinson's Disease -- 64. Deep Brain Stimulation for Dystonia -- 65. L-Dopa vs. MAO-B Inhibitors in Parkinson's Disease -- 66. Propranolol Treatment for Essential Tremor -- 67. Rasagiline in Parkinson's Disease -- 68. Botulinum a Toxin for Dystonia -- SECTION 9: MULTIPLE SCLEROSIS -- 69. Progressive Multifocal Leukoencephalopathy after Treatment with Natalizumab -- 70. Glucocorticoids for Optic Neuritis: The Optic Neuritis Treatment Trial -- 71. Neuromyelitis Optica Antibody in the Diagnosis of Neuromyelitis Optica -- 72. Correlation Between MRI Findings and Disability in Multiple Sclerosis -- 73. The Association of Vitamin D Levels and Multiple Sclerosis -- 74. Rate of Pregnancy-Related Relapse in Multiple Sclerosis -- SECTION 10: AUTOIMMUNE NEUROLOGY -- 75. EULAR Recommendations for Treatment of Primary CNS Vasculitis -- 76. NMDA-ab Receptor Encephalitis with Ovarian Teratoma -- 77. Identification of Sjogren's Syndrome Associated Ganglionopathy -- 78. IVIG for Stiff Person Syndrome -- SECTION 11: EPILEPSY -- 79. Lorazepam for Treatment of Status Epilepticus -- 80. Magnesium for the Prevention of Eclampsia -- 81. Antiepileptic Drug Treatment after a First Unprovoked Seizure.82. Intravenous vs. Intramuscular Benzodiazepines for Status Epilepticus -- 83. Continuous EEG Monitoring for Evaluation of Nonconvulsive Status Epilepticus -- SECTION 12: HEADACHE AND PAIN -- 84. Sumatriptan for Migraine -- 85. Topiramate for Migraine Prevention -- 86. Duloxetine for Chemo-Induced Painful Neuropathy -- 87. Pregabalin for Neuropathic Pain -- 88. Amitriptyline Prophylaxis for Headache -- 89. Divalproex for Migraine Prophylaxis -- SECTION 13: COGNITIVE NEUROLOGY -- 90. Donepezil for Alzheimer's Disease -- 91. Memantine in Addition to Donepezil for Alzheimer's Disease -- 92. Rivastigmine for Dementia with Lewy Bodies -- 93. Melatonin for REM Sleep Behavior Disorder -- 94. Agitation in Dementia -- SECTION 14: PEDIATRIC NEUROLOGY -- 95. Treatment of Infantile Spasms -- 96. Pharmaco vs. Behavioral Therapy for ADHD -- 97. Ketogenic Diet for the Treatment of Childhood Epilepsy -- 98. Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy -- 99. Febrile Seizures -- 100. When to Stop Antiepileptic Drugs in Children with Epilepsy -- INDEX.Nervous systemDiseasesTreatmentElectronic books.Nervous systemDiseasesTreatment.616.8046Brizzi Kate T.1042316MiAaPQMiAaPQMiAaPQBOOK9910467437803321Neurology evidence2466477UNINA